Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome ResistanceJames A. McCubrey, Alberto M. Martelli, Ferdinando Nicoletti et al.|Oncotarget|2012Cited by 317
Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response.James A. McCubrey, Alberto M. Martelli, Linda S. Steelman et al.|Oncotarget|2012Cited by 307
Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progressionGiancarlo Castellano, Massimo Libra, Elena Torrisi et al.|Cell Cycle|2010Cited by 57
Advances in Targeting Signal Transduction PathwaysJames A. McCubrey, Zoya N. Demidenko, Linda S. Steelman et al.|Oncotarget|2012Cited by 46
Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomasMassimo Libra, Antonino Carbone, Annunziata Gloghini et al.|Journal of Hepatology|2008Cited by 31